Preliminary Assessment of Tumor-Associated Tissue Eosinophilia (TATE) in Canine Mast Cell Tumors: Prevalence and Prognostic Relevance and Its Association with Neoangiogenesis

Simple Summary Mast cell tumor (MCT) is the most common malignant skin tumor in dogs. In order to gain more information on the prognostic markers of MCT, the role of the eosinophil granulocytes infiltrates was investigated and assessed by the evaluation of tumor-associated tissue eosinophilia (TATE) in 87 canine cutaneous MCTs. In human medicine, high TATE are often described in highly angiogenic tumors: we therefore assessed the vascular endothelial growth factor (VEGF) expression in neoplastic mast cells. TATE and VEGF expression were compared between themselves, with other variables expressing the biological behavior of the tumor, and with the recurrence. High grades of TATE resulted to be associated with less differentiated tumors, with higher recurrence rates, and with aberrant expression of KIT. This is the first evaluation of the association between TATE and the biologic behavior of MCTs. This study suggests that TATE investigation could be an important source of information for this tumor and for other neoplasms. Abstract Mast cell tumor (MCT) is the most common malignant skin tumor in dogs. In order to gain more information on the prognostic markers in MCT, the role of the eosinophil granulocytes infiltrates was investigated and assessed by the evaluation of tumor-associated tissue eosinophilia (TATE) in 87 canine cutaneous MCTs. In human medicine, high TATE are often described in highly angiogenic tumors: we therefore assessed the vascular endothelial growth factor (VEGF) expression in neoplastic mast cells. TATE and VEGF expression were compared between themselves, with histological grading, immunohistochemical expression of KIT and Ki-67, and with the recurrence. We found a statistically significant correlation between TATE and Patnaik grading (p = 0.041), Kiupel grading (p = 0.022), immunohistochemical KIT expression (p = 0.015), and tumor recurrence (p = 0.000). No associations were observed with Ki-67 and VEGF expression. This is the first evaluation of TATE and its prognostic value in canine MCTs in veterinary oncology. This study suggest that this investigation could be an important source of information for this tumor and for other neoplasms.

[1]  D. Berlato,et al.  Incomplete histological margins following planned narrow excision of canine appendicular soft tissue sarcomas and mast cell tumors, using the residual tumor classification scheme , 2022, Veterinary surgery : VS.

[2]  R. Laufer-Amorim,et al.  Diagnosis, Prognosis and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors , 2022, Cells.

[3]  L. Rigoli,et al.  Eosinophil exocytosis in a poorly differentiated tubular gastric adenocarcinoma: case report , 2022, Ultrastructural pathology.

[4]  E. Bellamy,et al.  Canine cutaneous and subcutaneous mast cell tumours: a review. , 2021, The Journal of small animal practice.

[5]  M. Longo,et al.  Preoperative planar lymphoscintigraphy allows for sentinel lymph node detection in 51 dogs improving staging accuracy: Feasibility and pitfalls , 2021, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.

[6]  R. Rasotto,et al.  Value, Limitations, and Recommendations for Grading of Canine Cutaneous Mast Cell Tumors: A Consensus of the Oncology-Pathology Working Group , 2021, Veterinary pathology.

[7]  F. Queiroga,et al.  Prognostic value of immunohistochemical markers in canine cutaneous mast cell tumours: A systematic review and meta-analysis. , 2021, Veterinary and comparative oncology.

[8]  S. Gondivkar,et al.  Tumor associated tissue eosinophilia in oral squamous cell carcinoma: A systematic review and meta-analysis. , 2021, Journal of oral biology and craniofacial research.

[9]  A. Santarelli,et al.  Tumour-associated tissue eosinophilia (TATE) in oral squamous cell carcinoma: a comprehensive review. , 2020, Histology and histopathology.

[10]  M. Campos,et al.  Canine and feline cutaneous mast cell tumour: a comprehensive review of treatments and outcomes. , 2020, Topics in companion animal medicine.

[11]  A. Hershey,et al.  Prognostic and Predictive Significance of KIT Protein Expression and c-kit Gene Mutation in Canine Cutaneous Mast Cell Tumours: A Consensus of the Oncology-Pathology Working Group. , 2019, Veterinary and comparative oncology.

[12]  M. Kiupel,et al.  Diagnosis and Prognosis of Canine Cutaneous Mast Cell Tumors. , 2019, The Veterinary clinics of North America. Small animal practice.

[13]  G. Sammarco,et al.  Mast Cells, Angiogenesis and Lymphangiogenesis in Human Gastric Cancer , 2019, International journal of molecular sciences.

[14]  I. Donev,et al.  Quantitative Analysis of Tumor-associated Tissue Eosinophilia in Recurring Bladder Cancer , 2018, Cureus.

[15]  F. Carneiro,et al.  New Insights Into the Role of Tissue Eosinophils in the Progression of Colorectal Cancer: A Literature Review. , 2018, Acta medica portuguesa.

[16]  G. Cassali,et al.  Assessment of Canine Mast Cell Tumor Mortality Risk Based on Clinical, Histologic, Immunohistochemical, and Molecular Features , 2018, Veterinary pathology.

[17]  R. Amini,et al.  An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome , 2018, European journal of haematology.

[18]  F. Levi-Schaffer,et al.  Bidirectional Mast Cell–Eosinophil Interactions in Inflammatory Disorders and Cancer , 2017, Front. Med..

[19]  Noel R. Rose,et al.  Eosinophils in Autoimmune Diseases , 2017, Front. Immunol..

[20]  A. Tanaka,et al.  Mast Cell Tumors , 2016 .

[21]  A. Munitz,et al.  Emerging Roles for Eosinophils in the Tumor Microenvironment. , 2016, Trends in cancer.

[22]  J. Mei,et al.  The infiltration and functional regulation of eosinophils induced by TSLP promote the proliferation of cervical cancer cell. , 2015, Cancer letters.

[23]  V. Grieco,et al.  Comparison of 2- and 3-category histologic grading systems for predicting the presence of metastasis at the time of initial evaluation in dogs with cutaneous mast cell tumors: 386 cases (2009-2014). , 2015, Journal of the American Veterinary Medical Association.

[24]  N. Rakesh,et al.  Tumour associated tissue eosinophilia as a predictor of locoregional recurrence in oral squamous cell carcinoma , 2015, Journal of clinical and experimental dentistry.

[25]  S. Sabattini,et al.  Histologic Grading of Canine Mast Cell Tumor , 2015, Veterinary pathology.

[26]  D. Worley.  Incorporation of sentinel lymph node mapping in dogs with mast cell tumours: 20 consecutive procedures. , 2014, Veterinary and comparative oncology.

[27]  M. Rothenberg,et al.  Eosinophils and Cancer , 2014, Cancer Immunology Research.

[28]  A. Caraffa,et al.  Vascular Endothelial Growth Factor (VEGF), Mast Cells and Inflammation , 2013, International journal of immunopathology and pharmacology.

[29]  M. Thomson,et al.  Evaluation of prognostic indicators in dogs with multiple, simultaneously occurring cutaneous mast cell tumours: 63 cases. , 2013, Veterinary and comparative oncology.

[30]  I. Bachelet,et al.  Interacting mast cells and eosinophils acquire an enhanced activation state in vitro , 2013, Allergy.

[31]  James J. Lee,et al.  The expanding role(s) of eosinophils in health and disease. , 2012, Blood.

[32]  M. Capron,et al.  Involvement of eosinophils in the anti-tumor response , 2012, Cancer Immunology, Immunotherapy.

[33]  A. Carvalho,et al.  Eosinophils may predict occult lymph node metastasis in early oral cancer , 2012, Clinical Oral Investigations.

[34]  J D Webster,et al.  Proposal of a 2-Tier Histologic Grading System for Canine Cutaneous Mast Cell Tumors to More Accurately Predict Biological Behavior , 2011, Veterinary pathology.

[35]  D. Etit,et al.  Tumor-Associated Tissue Eosinophilia as a Prognostic Factor in Squamous Cell Carcinoma of the Larynx , 2011, Indian Journal of Otolaryngology and Head & Neck Surgery.

[36]  R. L. Amorim,et al.  Immunohistochemical evaluation of prostaglandin E2 and vascular endothelial growth factor in canine cutaneous mast cell tumours. , 2010, Veterinary and comparative oncology.

[37]  T. Lombardi,et al.  Eosinophils and Oral Squamous Cell Carcinoma: A Short Review , 2009, Journal of oncology.

[38]  Craig Murdoch,et al.  The role of myeloid cells in the promotion of tumour angiogenesis , 2008, Nature Reviews Cancer.

[39]  R. M. Gil da Costa,et al.  CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers , 2007, BMC veterinary research.

[40]  C. Parish,et al.  Th2-mediated anti-tumour immunity: friend or foe? , 2007, Tissue antigens.

[41]  J. Webster,et al.  Cellular Proliferation in Canine Cutaneous Mast Cell Tumors: Associations with c-KIT and Its Role in Prognostication , 2007, Veterinary pathology.

[42]  Marc E. Rothenberg,et al.  Regulation of Carcinogenesis by IL-5 and CCL11: A Potential Role for Eosinophils in Tumor Immune Surveillance1 , 2007, The Journal of Immunology.

[43]  W. Pickl,et al.  Detection of vascular endothelial growth factor (VEGF) and VEGF receptors Flt-1 and KDR in canine mastocytoma cells. , 2007, Veterinary immunology and immunopathology.

[44]  F. Millanta,et al.  The role of vascular endothelial growth factor and its receptor Flk-1/KDR in promoting tumour angiogenesis in feline and canine mammary carcinomas: a preliminary study of autocrine and paracrine loops. , 2006, Research in veterinary science.

[45]  Takashi Suzuki,et al.  Tumor-associated tissue eosinophilia in human esophageal squamous cell carcinoma. , 2006, Anticancer research.

[46]  H. Yao,et al.  Prognostic Value of Survivin and Livin in Nasopharyngeal Carcinoma , 2006, The Laryngoscope.

[47]  J. Webster,et al.  Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours. , 2005, Journal of veterinary medicine. A, Physiology, pathology, clinical medicine.

[48]  S. Alrawi,et al.  Tissue Eosinophilic Infiltration: A Useful Marker for Assessing Stromal Invasion, Survival and Locoregional Recurrence in Head and Neck Squamous Neoplasia , 2005, Cancer journal.

[49]  S. Wiseman,et al.  Tissue eosinophilia: a morphologic marker for assessing stromal invasion in laryngeal squamous neoplasms , 2005, BMC clinical pathology.

[50]  D. Maślińska,et al.  Mast cell-derived VEGF and VEGF receptor type 1, 2, and 3 expression in human term trophoblast culture—influence of hypoxia , 2005, Inflammation Research.

[51]  M. Morini,et al.  Expression of the KIT Protein (CD117) in Primary Cutaneous Mast Cell Tumors of the Dog , 2004, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[52]  J. Webster,et al.  The Use of KIT and Tryptase Expression Patterns as Prognostic Tools for Canine Cutaneous Mast Cell Tumors , 2004, Veterinary pathology.

[53]  K. Smith,et al.  Relationships between the histological grade of cutaneous mast cell tumours in dogs, their survival and the efficacy of surgical resection , 2004, Veterinary Record.

[54]  H. Blattmann,et al.  Preliminary study of plasma vascular endothelial growth factor (VEGF) during low- and high-dose radiation therapy of dogs with spontaneous tumors. , 2004, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.

[55]  O. Paciello,et al.  Expression of vascular endothelial growth factor receptor Flk-1 in canine mammary tumours. , 2004, Journal of comparative pathology.

[56]  M. Wergin,et al.  Plasma vascular endothelial growth factor (VEGF) measured in seventy dogs with spontaneously occurring tumours. , 2004, In vivo.

[57]  L. Coussens,et al.  The tumor microenvironment: a critical determinant of neoplastic evolution. , 2003, European journal of cell biology.

[58]  G. De Vico,et al.  Expression of Vascular Endothelial Growth Factor in Canine Mammary Tumors , 2002, Veterinary pathology.

[59]  H. Yamanaka,et al.  Tumor‐associated tissue eosinophilia of penile cancer , 2002, International journal of urology : official journal of the Japanese Urological Association.

[60]  N. Ferrara,et al.  The role of VEGF in normal and neoplastic hematopoiesis , 2002, Journal of Molecular Medicine.

[61]  T. Kumamoto,et al.  Human muscle protein degradation in vitro by eosinophil cationic protein (ECP) , 2001, Muscle & nerve.

[62]  A. Harris,et al.  Expression of vascular endothelial growth factor by macrophages is up‐regulated in poorly vascularized areas of breast carcinomas , 2000, The Journal of pathology.

[63]  H. Adami,et al.  Infections as a major preventable cause of human cancer , 2000, Journal of internal medicine.

[64]  M. Merlin,et al.  Cervical carcinoma demonstrating tumor-associated tissue eosinophilia: a clinicopathological study of 17 patients. , 1999, Journal of lower genital tract disease.

[65]  M. Artuc,et al.  Mast cells and their mediators in cutaneous wound healing – active participants or innocent bystanders? , 1999, Experimental dermatology.

[66]  H. Dvorak,et al.  Mast Cells Can Secrete Vascular Permeability Factor/ Vascular Endothelial Cell Growth Factor and Exhibit Enhanced Release after Immunoglobulin E–dependent Upregulation of Fcε Receptor I Expression , 1998, The Journal of experimental medicine.

[67]  F. Askin,et al.  The Importance of the Eosinophil in Head and Neck Cancer , 1992, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[68]  P. Leder,et al.  Murine interleukin-4 displays potent anti-tumor activity in vivo , 1989, Cell.

[69]  P. Ihrke,et al.  Skin diseases of the dog and cat : clinical and histopathologic diagnosis , 2005 .

[70]  E. Macewen,et al.  Canine Cutaneous Mast Cell Tumor: Morphologic Grading and Survival Time in 83 Dogs , 1984, Veterinary pathology.

[71]  D. Lowe,et al.  Tumour-associated eosinophilia: a review. , 1981, Journal of clinical pathology.

[72]  D. Loegering,et al.  Cytotoxic properties of the eosinophil major basic protein. , 1979, Journal of immunology.

[73]  E. Goetzl,et al.  Tumor-associated eosinophilotactic factor. , 1974, The New England journal of medicine.

[74]  P. K. Goswami.  Local Subcutaneous Eosinophil Leucocytic Reaction to the Inoculation of Isolated Normal or Tumour Cells in Mice , 1964, British Journal of Cancer.

[75]  M. A. Weinberger.  Tumors in Domestic Animals , 1962 .